1-5 of 5
Chad Zik
Close
Sort by
Journal Articles

Partial Red Cell Exchange Is an Effective Tool for Adequately Reducing Hemoglobin S Levels in Patients with Sickle Cell Disease and Improving Patient Outcomes Including Reduction in Acute Care Utilization

Alan Sheinei, Chad Zik, Rania Fusisi, William B Ershler
Journal: Blood
Blood (2023) 142 (Supplement 1): 5288.
https://doi.org/10.1182/blood-2023-189044
Published: 2023
Journal Articles

How Sensitive Is the Sickle Prep? Clinical Implications

Sebastian R Mendez Marti, William B Ershler, Alan Sheinei, Chad Zik
Journal: Blood
Blood (2023) 142 (Supplement 1): 5335.
https://doi.org/10.1182/blood-2023-190718
Published: 2023
Journal Articles

Ineffective Erythropoiesis with Aging in Adults with Sickle Cell Disease

Upama Giri, Alan Sheinei, Chad Zik, Rania Fusisi, William B Ershler
Journal: Blood
Blood (2023) 142 (Supplement 1): 2505.
https://doi.org/10.1182/blood-2023-188068
Published: 2023
Journal Articles

Implementation of an Adult Sickle Cell Center Directly Correlates with Improved Patient Outcomes and Decreased Acute Care Utilization

Alan Sheinei, William B Ershler, Chad Zik, Rania Fusisi
Journal: Blood
Blood (2023) 142 (Supplement 1): 7235.
https://doi.org/10.1182/blood-2023-188979
Published: 2023
Journal Articles

Crizanlizumab Use in Recurrent Neurologic Symptoms Attributed to Sickle Cell Disease Induced Moyamoya Syndrome

Chad Zik, Sheinei Alan, William B. Ershler
Journal: Blood
Blood (2022) 140 (Supplement 1): 11157–11158.
https://doi.org/10.1182/blood-2022-170745
Published: 2022